| GlaxoSmithKline AG - Seretide 250, Dosier-Aerosol |
| 55552 | | 03 | | Seretide 250 | | Dosier-Aerosol | | R03AK06 | | Salmeterol and Fluticasone | | 29.11.2000 | | |
|
| Composition |
| salmeterolum 25 µg ut salmeteroli xinafoas, fluticasoni propionas 250 µg, norfluranum ad aerosolum pro dosi, doses pro vase 120. |
| Packungsbestandteile |
| Metered dose aerosol | | | | | | | | Active Agent | Dose |
|---|
| Fluticasoni Propionas | 250 µg | | Salmeterol | 25 µg |
| | BAG: Active Agent | Dose |
|---|
| Fluticasoni-17 Propionas | 250 mcg | | Salmeterol | 25 mcg |
| | | | Inactive agents |
|---|
| Norfluranum ad Aerosolum pro Dosi |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 120 unidose(s) | 71.88 | 94.60 | B | SL | Yes |
|
